Penumbra Income from Continuous Operations 2014-2025 | PEN
Penumbra annual/quarterly income from continuous operations history and growth rate from 2014 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
- Penumbra income from continuous operations for the quarter ending March 31, 2025 was $0.039B, a 256.51% increase year-over-year.
- Penumbra income from continuous operations for the twelve months ending March 31, 2025 was $0.042B, a 54.78% decline year-over-year.
- Penumbra annual income from continuous operations for 2024 was $0.014B, a 84.59% decline from 2023.
- Penumbra annual income from continuous operations for 2023 was $0.091B, a 4643.16% decline from 2022.
- Penumbra annual income from continuous operations for 2022 was $-0.002B, a 176.32% decline from 2021.
| Penumbra Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $14 |
| 2023 | $91 |
| 2022 | $-2 |
| 2021 | $3 |
| 2020 | $-19 |
| 2019 | $47 |
| 2018 | $3 |
| 2017 | $5 |
| 2016 | $15 |
| 2015 | $2 |
| 2014 | $2 |
| 2013 | $4 |
| Penumbra Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-03-31 | $39 |
| 2024-12-31 | $34 |
| 2024-09-30 | $30 |
| 2024-06-30 | $-60 |
| 2024-03-31 | $11 |
| 2023-12-31 | $54 |
| 2023-09-30 | $9 |
| 2023-06-30 | $19 |
| 2023-03-31 | $9 |
| 2022-12-31 | $4 |
| 2022-09-30 | $-2 |
| 2022-06-30 | $-4 |
| 2022-03-31 | $0 |
| 2021-12-31 | $-25 |
| 2021-09-30 | $8 |
| 2021-06-30 | $8 |
| 2021-03-31 | $11 |
| 2020-12-31 | $3 |
| 2020-09-30 | $-10 |
| 2020-06-30 | $-13 |
| 2020-03-31 | $1 |
| 2019-12-31 | $9 |
| 2019-09-30 | $11 |
| 2019-06-30 | $16 |
| 2019-03-31 | $10 |
| 2018-12-31 | $6 |
| 2018-09-30 | $-22 |
| 2018-06-30 | $13 |
| 2018-03-31 | $5 |
| 2017-12-31 | $9 |
| 2017-09-30 | $0 |
| 2017-06-30 | $-2 |
| 2017-03-31 | $-3 |
| 2016-12-31 | $-2 |
| 2016-09-30 | $12 |
| 2016-06-30 | $3 |
| 2016-03-31 | $2 |
| 2015-12-31 | $2 |
| 2015-09-30 | $1 |
| 2015-06-30 | $-3 |
| 2015-03-31 | $3 |
| 2014-12-31 | |
| 2014-09-30 | $0 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $11.463B | $1.195B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||